With a growing number of personal injury lawsuits pending nationwide on behalf of men and women suffering severe health issues following Artrium C-QUR hernia mesh surgery, on December 8, 2016, a panel of federal judges established a Multi-District Litigation (MDL No. 2753) to centralize all of the cases. Going forward, the Atrium C-QUR Mesh injury lawsuits are now coordinated for pretrial proceedings in the U.S. District Court for New Hampshire before Judge Landya B. McCafferty — In Re: Atrium Medical Corp. C-QUR Mesh Products Liability Litigation.
In 2005, Atrium first introduced C-QUR (pronounced “Secure”) Mesh through a 510(k) FDA approval system which allowed the medical device to be sold and implanted in patients without rigorous pre-market research and testing. Despite warnings of potential problems with the C-QUR design, Atrium distributed a long line of C-QUR mesh products for use in hernia repair, chest wall reconstruction and treatment of traumatic or surgical wounds, including:
• Atrium C-Qur Mesh
• Atrium C-Qur Mosaic
• Atrium C-Qur TacShield
• Atrium C-Qur V-Patch
• Atrium C-Qur Centrifx
• Atrium C-Qur FX Mesh (formerly C-Qur Lite)
All of these products are constructed out of a polypropylene mesh, with an outer coating of gel made from Omega-3 (fish oil) fatty acids. When the Atrium C-QUR mesh fails it can result in the need for revision surgery and leave patients with permanent and debilitating health issues.
The lawsuits claim the fish oil coating on C-QUR Mesh produces an allergic or inflammatory reaction that causes severe complications. In addition, if the hernia mesh adheres to the bowel, it could lead to the bowel becoming twisted or perforated, causing gastric ulcers or other serious intestinal problems.
The plaintiffs allege Atrium knew or should have known about the potential risk of internal injuries like bowel obstruction, chronic infection, and allergic reactions, however, the company withheld this information from patients and the medical community. In fact, the allegations against Atrium include that the company “stealth recalled” multiple types of C-QUR Mesh that had high rates of side effects by simply halting production without ever notifying doctors or patients.
The hernia mesh lawyers at Paglialunga & Harris, PS are reviewing cases for individuals who have experienced complications following a hernia repair or chest wall reconstruction where the surgeon may have implanted Atrium C-Qur Mesh. If you or somebody you know was diagnosed with a side effect of Atrium C-QUR Mesh, please contact our lawyers immediately for a free case consultation.
Comments for this article are closed.